Among brain tumours, there are both benign and malignant tumours.
Benign tumours include:
Malignant tumours include:
Surgery is the first treatment of choice for most benign and malignant tumours, either exclusively or followed by radiotherapy.
Treatment with radiotherapy—as radiosurgery in small tumours or as fractionated stereotactic radiotherapy or three-dimensional radiotherapy in larger tumours—may be an option in cases where the location of the tumour is either deep or in an area that may cause severe neurological aftereffects, or if the patient has problems with anaesthesia.
Chemotherapy is mainly used in malignant tumours, usually in combination with radiotherapy. Systemic treatment with anti-angiogenic agents, such as bevacizumab, may also be used.
The Service's team of professionals accompanies cancer patients throughout the whole disease process.
The neurosurgery unit's role is to care for the IVO patient when required.
A clinical trial is a research study carried out on people with the aim of learning more about how the body reacts to certain treatments. These trials generally seek to find drugs that are more effective than the current best therapeutic option for patients, or that have similar efficacy but a better toxicity profile.
Bearing in mind that almost all currently available treatments are the result of clinical research, the importance of clinical trials is obvious.
The IVO has a clinical trials unit for all types of tumours and participates in phase 1-3 studies as well as other types of studies.
Whether you receive the news of an initial diagnosis of cancer or a relapse, coping with cancer can be emotionally overwhelming. Each person has their own way of coping with a central nervous system tumour diagnosis, but there are some recommendations that can help you through this process: